Compare courses
Kenan-Flagler Business School

Executing Strategy for Competitive Advantage

Dec 9—11, 2019
3 days
Chapel Hill, North Carolina, United States
USD 4900
USD 1633 per day

How it works


Coursalytics is an independent platform to find, compare, and book executive courses. Coursalytics is not endorsed by, sponsored by, or otherwise affiliated with Kenan-Flagler Business School.

Full disclaimer.


Most organizations underestimate the challenges that come with strategy implementation and, despite best efforts, find that comprehensive and consistent execution occurs less frequently than desired. Executives who can recognize these problems and adapt accordingly will be most successful at moving the needle. Executing Strategy for Competitive Advantage teaches you how to navigate internal resistance and shifting external conditions to enact a strategy that drives superior performance.


  • Design an effective strategy for your business, function, or department
  • Create an execution plan that leverages strengths and mitigates risks
  • Implement strategy successfully, from planning; to quality decision-making; to change management
  • Prepare and support your team in making critical changes inside your organization
  • Use strategic planning tools to facilitate analysis


  Atul Nerkar research focuses on how technology, innovation and entrepreneurship affect business and corporate strategy. He studies research productivity in organizations and the evolution of technological capabilities in the context of the pharmaceutical, chemical and optical disc industries...
  Sreedhari Desai researches how individuals behave in organizations, with a focus on ethical decision making, fairness and gender diversity.  In her work on ethics, for instance, Dr. Desai investigates broadly the role of ethical nudges or non-coercive ways of leading people down moral pat...
Isin Guler Aran examines issues related to innovation strategy and international expansion. In her early work, she examined why venture capitalists fail to terminate investments in portfolio firms. Her recent publications have taken a social network approach to understanding why pharmaceutical fi...


Detailed Description
Detailed Description